Lakewood Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23M Sell
59,350
-53,000
-47% -$19.7M 1.18% 31
2026
Q1
$32.9M Sell
112,350
-9,500
-8% -$3.12M 2.08% 18
2025
Q4
$42.7M Sell
121,850
-179,800
-60% -$60.8M 2.83% 13
2025
Q3
$97.5M Buy
301,650
+99,500
+49% +$30.9M 7.35% 1
2025
Q2
$78.6M Buy
202,150
+12,000
+6% +$4.83M 5.87% 4
2025
Q1
$82.7M Buy
190,150
+11,500
+6% +$4.62M 7.21% 2
2024
Q4
$65.9M Buy
178,650
+79,150
+80% +$33.1M 5.91% 2
2024
Q3
$51.7M Buy
99,500
+16,500
+20% +$8.81M 4.07% 9
2024
Q2
$45M Buy
83,000
+5,000
+6% +$2.64M 3.67% 12
2024
Q1
$40.4M Buy
78,000
+16,000
+26% +$7.96M 3.3% 13
2023
Q4
$29.2M Hold
62,000
2.45% 16
2023
Q3
$27M Buy
62,000
+2,000
+3% +$907K 2.46% 15
2023
Q2
$26.7M Buy
+60,000
New +$27.7M 2.31% 16
2022
Q1
Sell
-80,939
Closed -$37.5M 63
2021
Q4
$37.5M Hold
80,939
1.59% 25
2021
Q3
$30.2M Sell
80,939
-32,000
-28% -$12.2M 1.33% 27
2021
Q2
$43.1M Sell
112,939
-121,500
-52% -$46.4M 1.78% 24
2021
Q1
$84.2M Buy
234,439
+13,000
+6% +$4.18M 3.57% 9
2020
Q4
$71.1M Sell
221,439
-59,000
-21% -$18.1M 3.33% 11
2020
Q3
$75.3M Buy
280,439
+32,700
+13% +$8.8M 3.63% 7
2020
Q2
$65.2M Buy
247,739
+62,300
+34% +$16.6M 2.8% 13
2020
Q1
$42.1M Buy
185,439
+439
+0.2% +$120K 1.93% 20
2019
Q4
$55.9M Buy
+185,000
New +$50.9M 1.98% 18

Other funds holding ELV

Lakewood Capital Management's ELV Position: Q2 2026 in Review

Lakewood Capital Management reduced its Elevance Health (ELV) stake by 47% in Q2 2026, selling an estimated $19.7M and leaving 59,350 shares worth $23M. The position accounts for 1.18% of the portfolio, ranked #31.

Lakewood Capital Management first reported a position in ELV in Q4 2019 and has held it in 22 quarters since. The position peaked at $97.5M in Q3 2025. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Lakewood Capital Management held 59,350 shares of Elevance Health worth $23M as of Q2 2026.
  • Lakewood Capital Management sold 53,000 Elevance Health shares in Q2 2026, an estimated $19.7M.
  • Elevance Health made up 1.18% of Lakewood Capital Management's portfolio in Q2 2026, its #31 holding.
  • Lakewood Capital Management first reported a position in Elevance Health in Q4 2019 and has held it in 22 quarters since.
  • Lakewood Capital Management's Elevance Health position peaked at $97.5M in Q3 2025.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Lakewood Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.